Pathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patients

• Published in: Haematologica (Roma) Vol. 104; no. 10; pp. 1962 - 1973
• Main Authors: Mori, Minako, Hira, Asuka, Yoshida, Kenichi, Muramatsu, Hideki, Okuno, Yusuke, Shiraishi, Yuichi, Anmae, Michiko, Yasuda, Jun, Tadaka, Shu, Kinoshita, Kengo, Osumi, Tomoo, Noguchi, Yasushi, Adachi, Souichi, Kobayashi, Ryoji, Kawabata, Hiroshi, Imai, Kohsuke, Morio, Tomohiro, Tamura, Kazuo, Takaori-Kondo, Akifumi, Yamamoto, Masayuki, Miyano, Satoru, Kojima, Seiji, Ito, Etsuro, Ogawa, Seishi, Matsuo, Keitaro, Yabe, Hiromasa, Yabe, Miharu, Takata, Minoru
• Format: Journal Article
• Language: English
• Published: Italy Ferrata Storti Foundation 01.10.2019
• Subjects: Medicin och hälsovetenskap
• ISSN: 0390-6078; 1592-8721; 1592-8721
• DOI: 10.3324/haematol.2018.207241

Fanconi anemia is a rare recessive disease characterized by multiple congenital abnormalities, progressive bone marrow failure, and a predisposition to malignancies. It results from mutations in one of the 22 known genes. The number of Japanese Fanconi anemia patients with a defined genetic diagnosis was relatively limited. In this study, we reveal the genetic subtyping and the characteristics of mutated genes in Japan and clarify the genotype-phenotype correlations. We studied 117 Japanese patients and successfully subtyped 97% of the cases. and pathogenic variants accounted for the disease in 58% and 25% of Fanconi anemia patients, respectively. We identified one and two hot spot mutations, which are found at low percentages (0.04-0.1%) in the whole-genome reference panel of 3,554 Japanese individuals (Tohoku Medical Megabank). was the third most common complementation group and only one case was identified in our series. Based on the data from the Tohoku Medical Megabank, we estimate that approximately 2.6% of Japanese are carriers of disease-causing gene variants, excluding missense mutations. This is the largest series of subtyped Japanese Fanconi anemia patients to date and the results will be useful for future clinical management.